Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | MMP12 | P39900 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP14 | P50281 | 1/20 | 0.43 |
| ▸ | MMP15 | P51511 | 1/20 | 0.43 |
| ▸ | MMP16 | P51512 | 1/20 | 0.43 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8775304 | 0.83 | KMT2A (0.57) | MAPTKMT2AMEN1NPC1PGR | |
| SCHEMBL2355800 | 0.81 | CDC25B (0.45) | MAPTKMT2AMEN1ALDH1A1CYP3A4 | |
| SCHEMBL6298374 | 0.78 | MDM2 (0.61) | MAPTKMT2AMEN1NPC1PGR | |
| SCHEMBL4161459 | 0.77 | MAPT (0.39) | MAPTLMNASMN1; SMN2 | |
| SCHEMBL4924113 | 0.77 | MAPT (0.47) | MAPTKMT2AMEN1NPC1PGR | |
| SCHEMBL9785098 | 0.76 | MDM2 (0.59) | MAPTKMT2AMEN1NPC1PGR | |
| SCHEMBL7594112 | 0.76 | MDM2 (0.50) | MAPTKMT2AMEN1NPC1PGR | |
| SCHEMBL912548 | 0.76 | MAPT (0.38) | MAPTKMT2AMEN1NPC1ALDH1A1 | |
| SCHEMBL4661808 | 0.76 | MAPT (0.38) | MAPTLMNASMN1; SMN2TSHR | |
| SCHEMBL867792 | 0.75 | LMNA (0.55) | MAPTNPC1ALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080217580-A1 | Organic Luminescent Element | TANABE JUNICHI | 2008-09-11 | — | — | US | disclosed |
| EP-1737925-A1 | NEW ORGANIC LUMINESCENT ELEMENT | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005100505-A1 | NEW ORGANIC LUMINESCENT ELEMENT | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080217580-A1 | Organic Luminescent Element | IK, ELOVL1, LEF1 | MAPT 1773/4885KMT2A 2270/4885MEN1 1865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.